{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":300,"width":600,"title":"    \ud83c\udfaf Septic Shock, Hemodynamic Support, A Neutral Trial with Important Lessons","description":"\ud83d\ude91 How much fluid is too much in septic shock? &amp;nbsp; The ARISE FLUIDS trial tackled one of critical care\u2019s most debated questions: should clinicians prioritize early vasopressors with restricted fluids or continue a more liberal fluid strategy? &amp;nbsp; \ud83d\udcca Among 963 patients with septic shock, early vasopressors reduced fluid exposure by &amp;gt;1 liter and significantly lowered pulmonary edema (0.6% vs 5.0%; P&amp;lt;0.001). &amp;nbsp; \ud83c\udfaf Yet there was no difference in 90-day days alive and out of hospital or mortality. &amp;nbsp; A landmark study reminding us that in septic shock, physiology is complex and more fluid is not always better\u2014but less fluid is not necessarily superior either. #Sepsis #CriticalCare #EmergencyMedicine #NEJM #MedicalEducation ","author_name":"Dr. RR Baliga's 'Podkast for the Kurious Doc'. Where Curiosity meets Clarity!","author_url":"http:\/\/www.MasterMedFacts.com","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/41618560\/height\/300\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/88AA3C\/\" height=\"300\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/content\/202897525"}